-The Hindu Company releases fact sheet detailing possible adverse events and those who are eligible for the vaccine Those with any history of allergies, fever and bleeding disorder, on blood thinners and who are immunity compromised or on medication have been told by COVAXIN manufacturer Bharat Biotech not to take the vaccine. A statement uploaded on the company website on Monday said the vaccine was also contraindicated for pregnant/lactating women, those using other...
More »SEARCH RESULT
Total Matching Records found : 323
India's real GDP to expand by 10.1% in FY2022: Icra
-Livemint.com/ PTI Icra expects the headline CPI inflation to decline to 4.6% in FY2022 from 6.4% in FY2021, while exceeding the mid-point of the Monetary Policy Committee's medium target of 4%, for the third consecutive year MUMBAI: Domestic rating agency Icra Ratings on Monday said it expects the country's real gross domestic product (GDP) to grow by 10.1% in FY2022. It, however, said the value of GDP in the next financial year will...
More »Experts raise questions over ‘hasty’ approval for COVID-19 Vaccines -Jacob Koshy
-The Hindu They advise against Covaxin, say there is no proof of efficacy. Several experts have raised concern over the “hasty approval” granted to the COVID-19 Vaccines despite the lack of adequate efficacy data. The Central Drugs Standard Control Organisation on Sunday accorded approval for restricted emergency use of the Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute of India (SII), and the indigenously developed vaccine Covaxin of Bharat Biotech. “I’m completely unaware...
More »India’s economy in 2020: Year of many questions -Anil Sasi
-The Indian Express India's economy in 2020: As Annus Horribilis 2020 comes to an end, there are positives in the economy: signs of a GDP rebound, and buoyant equity markets. But demand is weak, receipts are down, and the employment situation is grim. All eyes are on the Budget — and on the Vaccines In a little over a month, Finance Minister Nirmala Sitharaman will present what she has heralded as “a...
More »How India plans to ensure safety and efficacy of covid-19 Vaccines -Neetu Chandra Sharma
-Livemint.com India has adopted a cautious approach in granting approval to covid-19 Vaccines as fast tracking, safety and efficacy remain primary concern NEW DELHI: Safety and efficacy are the primary concerns of the government while granting emergency use authorization (EUA) to any covid-19 vaccine in the country. The government's cautious approach before approving a vaccine is apparent. The meeting of the subject expert committee of Central Drugs Standards Control Organisation on Wednesday asked...
More »
